Timothy B. Gardner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Timothy B. Gardner has a total of 370 co-authors. Here are the top co-authors by number of shared publications:
Stuart R. Gordon
Section of Gastroenterology and Hepatology
17 shared publications- Stuart R. Gordon
Section of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA
15 shared publications Kerrington D. Smith
Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH
10 shared publicationsAndres Gelrud
8 shared publications- David C. Whitcomb
University of Pittsburgh and UPMC
7 shared publications - Dhiraj Yadav
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
7 shared publications
Latest Publications
- 12 June 2026
- Published by Wolters Kluwer Health in Pancreas
- Vol. 55 (6) , e545-e546
Clinical Management Changes After EUS for Incidental Pancreatic Cysts: A Single-Center Experience
- 12 June 2026
- Published by Wolters Kluwer Health in Pancreas
- Vol. 55 (6) , e545-e546
Clinical Management Changes After EUS for Incidental Pancreatic Cysts: A Single-Center Experience
- 25 November 2025
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 28 (2)
Cystic Lesions and the Risk of Pancreatic Adenocarcinoma
- 25 November 2025
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 28 (2)
Cystic Lesions and the Risk of Pancreatic Adenocarcinoma
- 22 September 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (4) , 569-570
Pancreatic biopsy for indeterminate autoimmune pancreatitis: closer to eliminating misdiagnosis
- 22 September 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 102 (4) , 569-570
Pancreatic biopsy for indeterminate autoimmune pancreatitis: closer to eliminating misdiagnosis
- Open Access
- 14 May 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (2) , 337-344
The Effectiveness of Forceps-Assisted Cannulation for Difficult Cannulation During Endoscopic Retrograde Cholangiopancreatography: Results of the SOCCER Randomized Controlled Trial
INTRODUCTION: Forceps-assisted cannulation has been reported to facilitate difficult papillary cannulation during endoscopic retrograde cholangiopancreatography (ERCP), especially in the context of abnormal papillary anatomy or associated papillary diverticula. We performed a randomized, controlled trial to evaluate if forceps-assisted cannulation improves cannulation success rates, reduces the incidence of difficult cannulations, and decreases the risk of post-ERCP pancreatitis. METHODS: One hundred fifty-two patients with difficult papillary cannulation during ERCP were randomized to cannulation with or without forceps. Difficult cannulation was defined as follows: papilla in/on the rim of a diverticulum, difficult cannulation (defined as 5 or more attempts, 5 or more minutes, or 2 or more unintended pancreatic duct wire passages), redundant tissue overlaying the papilla, or a type 2, 3, or 4 papilla. The primary clinical outcome was rate of successful cannulation. RESULTS: In total, 70 patients underwent forceps-assisted cannulation and 81 did not use forceps. Forceps patients were younger (62 vs 68 years P = 0.009), but otherwise baseline demographics, ERCP indication, trainee involvement, and papilla classification were similar with failed initial cannulation the most common reason for enrollment. One hundred percent of patients in the forceps-assisted group vs 83.9% in the no forceps group ( P < 0.001) underwent successful cannulation. All patients in the no forceps group who crossed over to the forceps group had successful cannulation. Although not statistically significant, the difficult cannulation rate (57.1 vs 69.1, P = 0.132) was higher in the no forceps group and the post-ERCP pancreatitis rate was low in both groups (5.7 vs 3.7, P = 0.705). DISCUSSION: Using forceps-assisted technique to overcome difficult cannulation improves ERCP cannulation success rates.
- 14 May 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (2) , 337-344
Open AccessThe Effectiveness of Forceps-Assisted Cannulation for Difficult Cannulation During Endoscopic Retrograde Cholangiopancreatography: Results of the SOCCER Randomized Controlled Trial
INTRODUCTION: Forceps-assisted cannulation has been reported to facilitate difficult papillary cannulation during endoscopic retrograde cholangiopancreatography (ERCP), especially in the context of abnormal papillary anatomy or associated papillary diverticula. We performed a randomized, controlled trial to evaluate if forceps-assisted cannulation improves cannulation success rates, reduces the incidence of difficult cannulations, and decreases the risk of post-ERCP pancreatitis. METHODS: One hundred fifty-two patients with difficult papillary cannulation during ERCP were randomized to cannulation with or without forceps. Difficult cannulation was defined as follows: papilla in/on the rim of a diverticulum, difficult cannulation (defined as 5 or more attempts, 5 or more minutes, or 2 or more unintended pancreatic duct wire passages), redundant tissue overlaying the papilla, or a type 2, 3, or 4 papilla. The primary clinical outcome was rate of successful cannulation. RESULTS: In total, 70 patients underwent forceps-assisted cannulation and 81 did not use forceps. Forceps patients were younger (62 vs 68 years P = 0.009), but otherwise baseline demographics, ERCP indication, trainee involvement, and papilla classification were similar with failed initial cannulation the most common reason for enrollment. One hundred percent of patients in the forceps-assisted group vs 83.9% in the no forceps group ( P < 0.001) underwent successful cannulation. All patients in the no forceps group who crossed over to the forceps group had successful cannulation. Although not statistically significant, the difficult cannulation rate (57.1 vs 69.1, P = 0.132) was higher in the no forceps group and the post-ERCP pancreatitis rate was low in both groups (5.7 vs 3.7, P = 0.705). DISCUSSION: Using forceps-assisted technique to overcome difficult cannulation improves ERCP cannulation success rates.
- 1 May 2025
- Published by Elsevier in Pancreatology
- Vol. 25 (4) , 528-533
Comparison of thrombosis risk in patients undergoing purified and non-purified islet cell transplantation
- 1 May 2025
- Published by Elsevier in Pancreatology
- Vol. 25 (4) , 528-533
Comparison of thrombosis risk in patients undergoing purified and non-purified islet cell transplantation
- 14 September 2024
- Published by Elsevier in Gastroenterology
- Vol. 168 (1) , 186-187
Reply
- 13 August 2024
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 101 (1) , 129-138.e0
Development and validation of a machine learning–based, point-of-care risk calculator for post-ERCP pancreatitis and prophylaxis selection
- 13 August 2024
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 101 (1) , 129-138.e0
Development and validation of a machine learning–based, point-of-care risk calculator for post-ERCP pancreatitis and prophylaxis selection
- 1 May 2024
- Published by Wolters Kluwer Health in Pancreas
- Vol. 53 (8) , e652-e656
Quality of Life Following Total Pancreatectomy With Islet Autotransplantation
Objectives: Total pancreatectomy with islet autotransplantation (TPIAT) is performed to improve the quality of life (QOL) of patients with chronic pancreatitis. Few reports have documented QOL following TPIAT, with none using the pancreatitis-specific Pancreatitis Quality of Life Instrument (PANQOLI). We surveyed patients at our center who underwent TPIAT to document postoperative QOL. Materials and Methods: We collected survey data from 18 adult patients who underwent TPIAT at our medical center from 2012 to 2020. Patients were asked questions assessing QOL following TPIAT and completed the Short-Form Health Survey and PANQOLI instruments. Results: Forty-three patients who underwent TPIAT were mailed surveys, and 18 were returned. The mean age was 45 years, and 67% of respondents were female. Almost half (44%) had hereditary pancreatitis. Sixty-seven percent believed that their overall QOL had improved after surgery. The mean postoperative Short-Form Health Survey physical score was 38.9 and mean mental score was 44. The mean PANQOLI score was 66 (physical function 20, role function 16, emotional function 14, self-worth 15). Following surgery, 33% were using opiate medications and 67% were using antihyperglycemic medications. Conclusions: TPIAT resulted in improved self-reported QOL in most patients, although postoperative physical and mental QOL are less compared to the average healthy United States adult.
- 1 May 2024
- Published by Wolters Kluwer Health in Pancreas
- Vol. 53 (8) , e652-e656
Quality of Life Following Total Pancreatectomy With Islet Autotransplantation
Objectives: Total pancreatectomy with islet autotransplantation (TPIAT) is performed to improve the quality of life (QOL) of patients with chronic pancreatitis. Few reports have documented QOL following TPIAT, with none using the pancreatitis-specific Pancreatitis Quality of Life Instrument (PANQOLI). We surveyed patients at our center who underwent TPIAT to document postoperative QOL. Materials and Methods: We collected survey data from 18 adult patients who underwent TPIAT at our medical center from 2012 to 2020. Patients were asked questions assessing QOL following TPIAT and completed the Short-Form Health Survey and PANQOLI instruments. Results: Forty-three patients who underwent TPIAT were mailed surveys, and 18 were returned. The mean age was 45 years, and 67% of respondents were female. Almost half (44%) had hereditary pancreatitis. Sixty-seven percent believed that their overall QOL had improved after surgery. The mean postoperative Short-Form Health Survey physical score was 38.9 and mean mental score was 44. The mean PANQOLI score was 66 (physical function 20, role function 16, emotional function 14, self-worth 15). Following surgery, 33% were using opiate medications and 67% were using antihyperglycemic medications. Conclusions: TPIAT resulted in improved self-reported QOL in most patients, although postoperative physical and mental QOL are less compared to the average healthy United States adult.
- Top Cited Papers
- 3 March 2024
- Published by Elsevier in Gastroenterology
- Vol. 167 (3) , 454-468
Diagnosis and Management of Pancreatic Cysts
- 3 March 2024
- Published by Elsevier in Gastroenterology
- Vol. 167 (3) , 454-468
Top Cited PapersDiagnosis and Management of Pancreatic Cysts